These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26558781)

  • 21. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
    Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
    Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma.
    Li R; Gao K; Luo H; Wang X; Shi Y; Dong Q; Luan W; You Y
    J Exp Clin Cancer Res; 2014 Jan; 33(1):9. PubMed ID: 24438238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
    Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
    Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J
    Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
    Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
    J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.
    Huang T; Alvarez AA; Pangeni RP; Horbinski CM; Lu S; Kim SH; James CD; J Raizer J; A Kessler J; Brenann CW; Sulman EP; Finocchiaro G; Tan M; Nishikawa R; Lu X; Nakano I; Hu B; Cheng SY
    Nat Commun; 2016 Oct; 7():12885. PubMed ID: 27698350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
    Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
    Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma.
    Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG
    Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1.
    Guo X; Piao H; Zhang Y; Sun P; Yao B
    Bosn J Basic Med Sci; 2020 Nov; 20(4):459-470. PubMed ID: 31999936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.
    Huang Q; Zhang XW; Ma YS; Lu GX; Xie RT; Yang HQ; Lv ZW; Zhong XM; Liu T; Huang SX; Fu D; Xie C
    Jpn J Clin Oncol; 2017 Jul; 47(7):590-596. PubMed ID: 28531325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
    Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.
    Hägerstrand D; He X; Bradic Lindh M; Hoefs S; Hesselager G; Ostman A; Nistér M
    Neuro Oncol; 2011 Nov; 13(11):1178-91. PubMed ID: 21940738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
    Qi J; Pan L; Yu Z; Ni W
    Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.